Tasneem Arsiwala

Tasneem Arsiwala

West Virginia University

H-index: 7

North America-United States

About Tasneem Arsiwala

Tasneem Arsiwala, With an exceptional h-index of 7 and a recent h-index of 7 (since 2020), a distinguished researcher at West Virginia University, specializes in the field of Pharmacokinetics, Blood-brain barrier, Drug delivery, Brain Tumors.

His recent articles reflect a diverse array of research interests and contributions to the field:

Ultrasound Blood–Brain Barrier Opening and Aducanumab in Alzheimer’s Disease

Coordination of anti-CTLA-4 with whole-brain radiation therapy decreases tumor burden during treatment in a novel syngeneic model of lung cancer brain metastasis

BSBM-11 COMBINING IMMUNOTHERAPY AND WHOLE-BRAIN RADIATION THERAPY IN A NOVEL SYNGENEIC LUNG CANCER BRAIN METASTASIS PRECLINICAL MODEL: DOES TIMING OF ADMINISTRATION MATTER?

BSBM-10 CHARACTERIZATION OF A RADIATION-RESISTANT MODEL OF LUNG CANCER BRAIN METASTASIS

Abstract P2-21-05: Vascular effects of Platelet-derived growth factor-B (PDGFB) in breast cancer metastasis to the brain

Blood-tumor barrier opening by MRI-guided transcranial focused ultrasound in a preclinical breast cancer brain metastasis model improves efficacy of combinatorial chemotherapy

Effects of whole-brain radiation therapy on the blood-brain barrier in immunocompetent and immunocompromised mouse models

Single exposure to low-intensity focused ultrasound causes biphasic opening of the blood-brain barrier on the sonicated and contralateral treated regions.

Tasneem Arsiwala Information

University

Position

Doctoral Candidate

Citations(all)

192

Citations(since 2020)

192

Cited By

25

hIndex(all)

7

hIndex(since 2020)

7

i10Index(all)

6

i10Index(since 2020)

6

Email

University Profile Page

Google Scholar

Tasneem Arsiwala Skills & Research Interests

Pharmacokinetics

Blood-brain barrier

Drug delivery

Brain Tumors

Top articles of Tasneem Arsiwala

Ultrasound Blood–Brain Barrier Opening and Aducanumab in Alzheimer’s Disease

New England Journal of Medicine

2024/1/4

Coordination of anti-CTLA-4 with whole-brain radiation therapy decreases tumor burden during treatment in a novel syngeneic model of lung cancer brain metastasis

Cancer Immunology, Immunotherapy

2024/1

BSBM-11 COMBINING IMMUNOTHERAPY AND WHOLE-BRAIN RADIATION THERAPY IN A NOVEL SYNGENEIC LUNG CANCER BRAIN METASTASIS PRECLINICAL MODEL: DOES TIMING OF ADMINISTRATION MATTER?

Neuro-Oncology Advances

2023/8

Samuel Sprowls
Samuel Sprowls

H-Index: 4

Tasneem Arsiwala
Tasneem Arsiwala

H-Index: 2

BSBM-10 CHARACTERIZATION OF A RADIATION-RESISTANT MODEL OF LUNG CANCER BRAIN METASTASIS

Neuro-Oncology Advances

2023/8

Tasneem Arsiwala
Tasneem Arsiwala

H-Index: 2

Abstract P2-21-05: Vascular effects of Platelet-derived growth factor-B (PDGFB) in breast cancer metastasis to the brain

Cancer Research

2023/3/1

Tasneem Arsiwala
Tasneem Arsiwala

H-Index: 2

Blood-tumor barrier opening by MRI-guided transcranial focused ultrasound in a preclinical breast cancer brain metastasis model improves efficacy of combinatorial chemotherapy

Frontiers in Oncology

2023/2/10

Effects of whole-brain radiation therapy on the blood-brain barrier in immunocompetent and immunocompromised mouse models

Rad Oncology

2023/2/3

Single exposure to low-intensity focused ultrasound causes biphasic opening of the blood-brain barrier on the sonicated and contralateral treated regions.

Exploiting modulation of the Blood-Brain and Blood-Tumor Barrier permeability by Translational Focused Ultrasound for therapeutic delivery to CNS metastases

2022

Exploiting modulation of the Blood-Brain and Blood-Tumor Barrier permeability by Translational Focused Ultrasound for therapeutic delivery to CNS metastases

2022

Characterization of passive permeability after low intensity focused ultrasound mediated blood–brain barrier disruption in a preclinical model

Fluids and Barriers of the CNS

2022/9/8

Focused ultrasound induced blood-tumor barrier permeability of combinatorial chemotherapy

Cancer Research

2022/6/15

Modulation of the blood-tumor barrier to enhance drug delivery and efficacy for brain metastases

Neuro-Oncology Advances

2021/11/1

Overcoming the acquired resistance to gefitinib in lung cancer brain metastasis in vitro and in vivo

Archives of toxicology

2021/11

Ultrasound-mediated disruption of the blood tumor barrier for improved therapeutic delivery

2021/7/1

A Review of Mathematics Determining Solute Uptake at the Blood–Brain Barrier in Normal and Pathological Conditions

2021/5/19

Pushkar Saralkar
Pushkar Saralkar

H-Index: 4

Tasneem Arsiwala
Tasneem Arsiwala

H-Index: 2

The mitochondrial mitoNEET ligand NL-1 is protective in a murine model of transient cerebral ischemic stroke

Pharmaceutical Research

2021/5

Hypomethylating agent azacitidine is effective in treating brain metastasis triple-negative breast cancer through regulation of DNA methylation of keratin 18 gene

Translational Oncology

2020/6/1

Nanoparticle formulation and in vitro efficacy testing of the mitoNEET ligand NL-1 for drug delivery in a brain endothelial model of ischemic reperfusion-injury

International journal of pharmaceutics

2020/3/30

Pushkar Saralkar
Pushkar Saralkar

H-Index: 4

Tasneem Arsiwala
Tasneem Arsiwala

H-Index: 2

Radiation increases BTB permeability in a preclinical model of breast cancer brain metastasis.

2020/2/12

See List of Professors in Tasneem Arsiwala University(West Virginia University)

Co-Authors

academic-engine